Good Life Project: Groundbreaking Cancer Research with Dr. Matthew D. Park, PhD

Episode Release Date: February 24, 2025
Host: Jonathan Fields
Guest: Dr. Matthew D. Park, PhD

Introduction

In this compelling episode of the Good Life Project, host Jonathan Fields engages in an insightful conversation with Dr. Matthew D. Park, a pioneering immunologist at Mount Sinai. Dr. Park delves into his groundbreaking research on how the aging immune system influences cancer development and explores innovative avenues for both cancer prevention and treatment. This discussion not only sheds light on the intricate relationship between aging and cancer but also opens doors to potential applications in other age-related diseases.

The Aging Immune System and Cancer Predisposition

Dr. Park begins by addressing a fundamental question: Why are older individuals more susceptible to cancer? He explains that the aging of the immune system is a primary factor contributing to this increased risk.

Dr. Matthew Park [00:00]: "Aging of the immune system is what seems to be the main driving factor for why older folks are more predisposed to cancer."

Dr. Park emphasizes that while aging inherently affects the immune system, lifestyle factors—such as diet, exercise, and sleep—can modulate these changes. For instance, obesity is closely linked to the production of certain immune cells that may promote tumor growth.

Dr. Matthew Park [00:30]: "There are many lifestyle variables that can modulate the changes to the immune system that happen with age... obesity is very tightly linked... to tumor development and progression."

Research Insights: Myeloid Cells and Natural Killer (NK) Cells

A significant portion of Dr. Park's research focuses on the role of myeloid cells in the tumor microenvironment. These cells, typically the body's first responders to infections, paradoxically suppress the activity of tumor-fighting NK cells in older individuals, thereby facilitating cancer progression.

Dr. Matthew Park [08:17]: "Myeloid cells... dampen inflammation, prevent things from getting worse. We call them immunosuppressive... they inhibit the activity of those tumor killing cells, the white blood cells."

Through experiments involving bone marrow transplants in mice, Dr. Park demonstrated that an old immune system leads to worse cancer outcomes, regardless of the recipient's age. Conversely, transplanting a young immune system into older mice resulted in significantly smaller tumors, highlighting the pivotal role of immune aging.

Dr. Matthew Park [12:29]: "If the donor bone marrow was old, then you had worse cancer progression... it's the age of the immune system that determines how quickly your cancer will develop and grow."

Innovative Therapeutic Approaches: Repurposing Existing Medications

One of the most exciting aspects of Dr. Park's research is the repurposing of existing FDA-approved medications to disrupt the detrimental feedback loop between myeloid cells and cancer progression. Specifically, drugs like Anakinra (originally for rheumatoid arthritis) and dupilumab (DUPIXENT) (commonly used for eczema) have shown promise in blocking inflammatory pathways that exacerbate cancer growth.

Dr. Matthew Park [22:16]: "Blocking IL1 using Anakinra... reduces the progression of colorectal and pancreatic cancer."

Early-phase clinical trials at Mount Sinai are currently testing these medications on patients with late-stage cancers who have not responded to conventional therapies. Preliminary results indicate a superior anti-tumor response in patients treated with these drugs, offering hope for more manageable and less toxic cancer treatments.

Dr. Matthew Park [26:37]: "We are very excited... response in some of these patients where the intervention of dupilumab and Anakinra has successfully reset the bone marrow."

Broader Implications: Beyond Cancer

Dr. Park's research transcends cancer, offering potential insights into other age-related diseases such as cardiovascular disease, neurodegenerative disorders, and infections. The common thread is the dysregulation of myeloid cells due to aging, which contributes to various forms of organ dysfunction and disease progression.

Dr. Matthew Park [46:57]: "Myeloid cells are one of the driving causes of atherosclerosis, hypertension, heart failure, dementia... preventing these pathogenic myeloid cells could alleviate detrimental effects of these diseases."

Additionally, his team is exploring ways to repopulate tissue-resident myeloid cells, which are crucial for maintaining organ health and function. For example, restoring alveolar macrophages in the lungs could enhance gas exchange and improve responses to respiratory infections like the flu.

Dr. Matthew Park [50:43]: "We are currently working on repopulating the alveolar macrophages... to see if we can rescue lung function in old mice."

The Balance Within the Immune System

A recurring theme in Dr. Park's discussion is the balancing act required within the immune system. On one hand, it's essential to suppress pathogenic myeloid cells that hinder cancer-fighting mechanisms. On the other hand, maintaining or restoring beneficial tissue-resident myeloid cells is crucial for overall health and disease resistance.

Host [56:14]: "It's like... how do we find interventions or therapies that affect the ones we want to suppress while not having the same effect on the ones we want to support?"

Dr. Park acknowledges this complexity and highlights it as a central challenge in aging research, but also expresses optimism given the current understanding of immune system dynamics.

Dr. Matthew Park [56:14]: "This is the challenge that will become the highlight of aging research... but also a very hopeful problem."

Practical Implications and Recommendations

For listeners approaching the later stages of life, Dr. Park offers practical advice grounded in research:

1. Exercise: Promotes the preservation of tissue-resident macrophages and mitigates the production of harmful myeloid cells.
2. Sleep: Adequate and quality sleep is vital for maintaining a balanced immune system. Poor sleep can lead to an increase in pathogenic myeloid cell production.
3. Diet: A balanced diet, avoiding high-fat and obesity-linked foods, can help regulate immune cell composition.

Dr. Matthew Park [57:47]: "Exercise... sleep... diet... are very well supported... keeping your immune system younger."

He also touches on the emerging research surrounding intermittent fasting, which has been shown to reduce myeloid cell production, further supporting immune health.

Dr. Matthew Park [61:19]: "Intermittent fasting... reduces the production and output of myeloid cells from the bone marrow."

Future Directions and Hope

Looking ahead, Dr. Park is optimistic about the translational potential of his research. The ongoing clinical trials and future studies aim to expand the application of these findings, potentially revolutionizing how we approach not only cancer but a myriad of age-related diseases.

Dr. Matthew Park [63:31]: "This kind of translational research is possible... bringing it back to those who actually need it."

He underscores the importance of continued research and collaboration to fully harness the benefits of manipulating the immune system in aging populations.

Reflections on Living a Good Life

In closing, when prompted to reflect on living a good life, Dr. Park encapsulates his philosophy by emphasizing awareness and informed choices.

Dr. Matthew Park [65:31]: "To live a good life is to listen to your body, to understand... why you may not feel good, but also why you do feel good. And knowledge is power."

Conclusion

Dr. Matthew D. Park's research offers a beacon of hope in the fight against cancer and other age-related diseases. By unraveling the complexities of the aging immune system and exploring innovative therapeutic strategies, his work stands poised to make significant strides in enhancing longevity and quality of life. This episode of the Good Life Project not only informs but inspires listeners to take proactive steps in supporting their health as they age.

Notable Quotes:

• Dr. Matthew Park [00:00]: "Aging of the immune system is what seems to be the main driving factor for why older folks are more predisposed to cancer."

• Dr. Matthew Park [12:29]: "It's the age of the immune system that determines how quickly your cancer will develop and grow."

• Dr. Matthew Park [26:37]: "Response in some of these patients where the intervention of dupilumab and Anakinra has successfully reset the bone marrow."

• Dr. Matthew Park [56:14]: "The challenge that will become the highlight of aging research... but also a very hopeful problem."

• Dr. Matthew Park [65:31]: "To live a good life is to listen to your body... And knowledge is power."

This episode underscores the intricate dance between our immune systems and aging, highlighting both the challenges and the promising avenues for future research and therapeutic intervention. Through informed lifestyle choices and groundbreaking scientific advancements, the pursuit of a good and healthy life becomes increasingly attainable.